MAGNESIUM SULFATE injection, solution

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

MAGNESIUM SULFATE (UNII: DE08037SAB) (Magnesium Cation - UNII:T6V3LHY838)

Available from:

Cantrell Drug Company

INN (International Name):

MAGNESIUM SULFATE

Composition:

MAGNESIUM SULFATE 20 g in 250 mL

Administration route:

INTRAVENOUS

Prescription type:

PRESCRIPTION DRUG

Authorization status:

unapproved drug other

Summary of Product characteristics

MAGNESIUM SULFATE - MAGNESIUM SULFATE INJECTION, SOLUTION
CANTRELL DRUG COMPANY
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
MAGNESIUM SULFATE 20 G ADDED TO 5% DEXTROSE 250 ML BAG
LABEL
MAGNESIUM SULFATE
magnesium sulfate injection, solution
Cantrell Drug Company
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:52533-10 7
ROUTE OF ADMINISTRATION
INTRAVENOUS
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
MAGNESIUM SULFATE (UNII: DE0 8 0 37SAB) (Magnesium Catio n - UNII:T6
V3LHY8 38 )
MAGNESIUM SULFATE
20 g in 250 mL
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
DEXTRO SE (UNII: IY9 XDZ35W2)
12.5 g in 250 mL
WA TER (UNII: 0 59 QF0 KO0 R)
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:52533-10 7-38
250 mL in 1 BAG
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 7/25/20 11
LABELER -
Cantrell Drug Company (035545763)
Revised: 11/2012